4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-013697
Chief Legal Officer sold 290 shares at $10.71 ($3,106)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SUMER JACQUELYN L Chief Legal Officer | 2023-04-18 | Sale | −290 | $10.71 | $3,106 | 46,405 | D |
| Open-market sales · 290 sh · avg $10.71 · $3,106 | |||||||
Loading xslF345X04/ownership.xml…